Literature DB >> 27392978

Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.

Y Dickstein1, R Edelman2, T Dror2, K Hussein3, Y Bar-Lavie4, M Paul3.   

Abstract

OBJECTIVES: To examine whether carbapenem-resistant Enterobacteriaceae (CRE) carriage is associated with incidence of clinical infection as a means of assessing whether the morbidity and mortality associated with these bacteria are mediated by underlying conditions or intrinsic properties of CRE.
METHODS: This retrospective matched cohort study compared the incidence of invasive infections in CRE-colonized patients and matched non-carriers in the intensive care unit (ICU). The primary outcome was infection caused by CRE of the same species as the colonizing strain among CRE carriers, and infections caused by carbapenem-sensitive strains of the same organism in non-carriers. Hospital discharge and death were considered as competing events. Competing-risks hazard analysis was performed for the entire cohort and for a nested cohort matched by Acute Physiology and Chronic Health Evaluation (APACHE) II scores, stratified by matching.
RESULTS: In total, 146 CRE carriers were compared with 292 non-carriers. Patients were well matched for most risk factors for Enterobacteriaceae infection, including age, renal failure, previous invasive infection, previous hospitalization, APACHE II score, length of mechanical ventilation, length of hospitalization and CRE carriage. On regression analysis, colonization with CRE was independently associated with Enterobacteriaceae infection {cause-specific hazard ratio (CSHR) 2.06 [95% confidence interval (CI) 1.03-4.09]}. On regression analysis of the APACHE-II-matched cohort (N=284), colonization with CRE remained significantly associated with Enterobacteriaceae infection [CSHR 3.32 (95% CI 1.31-8.43)].
CONCLUSIONS: Colonization with CRE was associated with at least a two-fold increased risk of infection by the colonizing strain amongst ICU patients.
Copyright © 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae; Colonization; Infection; Invasiveness; Virulence

Mesh:

Substances:

Year:  2016        PMID: 27392978     DOI: 10.1016/j.jhin.2016.05.018

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  18 in total

1.  Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Authors:  Katherine E Goodman; Patricia J Simner; Eili Y Klein; Abida Q Kazmi; Avinash Gadala; Matthew F Toerper; Scott Levin; Pranita D Tamma; Clare Rock; Sara E Cosgrove; Lisa L Maragakis; Aaron M Milstone
Journal:  Infect Control Hosp Epidemiol       Date:  2019-03-27       Impact factor: 3.254

2.  Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Weijie Cao; Jieyong Zhang; Zhilei Bian; Li Li; Suping Zhang; Yang Qin; Dingming Wan; Zhongxing Jiang; Ran Zhang
Journal:  Infect Drug Resist       Date:  2022-10-18       Impact factor: 4.177

Review 3.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

4.  Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales.

Authors:  Jessica R Howard-Anderson; Michelle Earley; Lauren Komarow; Lilian Abbo; Deverick J Anderson; Jason C Gallagher; Matthew Grant; Angela Kim; Robert A Bonomo; David van Duin; L Silvia Muñoz-Price; Jesse T Jacob
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-02       Impact factor: 6.520

5.  Hospital-acquired colonization and infections in a Vietnamese intensive care unit.

Authors:  Duong Bich Thuy; James Campbell; Le Thanh Hoang Nhat; Nguyen Van Minh Hoang; Nguyen Van Hao; Stephen Baker; Ronald B Geskus; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Prevalence and Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.

Authors:  Jin Suk Kang; Jongyoun Yi; Mee Kyung Ko; Soon Ok Lee; Jeong Eun Lee; Kye Hyung Kim
Journal:  J Korean Med Sci       Date:  2019-05-13       Impact factor: 2.153

7.  Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

Authors:  Qun Lin; Yue Wang; Jing Yu; Shusheng Li; Yicheng Zhang; Hui Wang; Xiaoquan Lai; Dong Liu; Liyan Mao; Ying Luo; Guoxing Tang; Zhongju Chen; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090

8.  Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.

Authors:  Thomas Howe McConville; Sean Berger Sullivan; Angela Gomez-Simmonds; Susan Whittier; Anne-Catrin Uhlemann
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

9.  [Clinical significance and risk factors for multidrug resistant Enterobacteriaceae colonization].

Authors:  A Padilla-Serrano; J J Serrano-Castañeda; R Carranza-González; M P García-Bonillo
Journal:  Rev Esp Quimioter       Date:  2018-05-04       Impact factor: 1.553

10.  Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?

Authors:  Ting-Ting Yang; Xue-Ping Luo; Qing Yang; Hong-Chao Chen; Yi Luo; Yan-Min Zhao; Yi-Shan Ye; Xiao-Yu Lai; Jian Yu; Ya-Min Tan; Guo-Qing Wei; He Huang; Ji-Min Shi
Journal:  Antimicrob Resist Infect Control       Date:  2020-03-17       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.